MaaT Pharma Overview

  • Founded
  • 2014
Founded
  • Status
  • Private
  • Employees
  • 34
Employees
  • Latest Deal Type
  • Series B
  • Latest Deal Amount
  • $30M
Latest Deal Amount
  • Investors
  • 9

MaaT Pharma General Information

Description

Developer of microbiome restoration biotherapeutics designed to improve the survival outcome of blood cancer. The company's biotherapeutics focus on onco-hematology and acute myeloid leukemia, enabling doctors to treat life-threatening diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • 317 Avenue Jean Jaurès
  • 69007 Lyon
  • France
+33 04 00 00 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

MaaT Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series B) 01-Dec-2020 $30M 000.00 000.00 Completed Clinical Trials - Phase 2
4. Accelerator/Incubator 29-Oct-2016 00.000 Completed Startup
3. Early Stage VC (Series A) 22-Mar-2016 000.00 00.000 000.00 Completed Startup
2. Early Stage VC 24-Jul-2015 $1.11M $2.33M Completed Startup
1. Seed Round 09-Jan-2015 $1.22M $1.22M Completed Startup
To view MaaT Pharma’s complete valuation and funding history, request access »

MaaT Pharma Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
P3 Shares 000,000 00.000000 000.00 000.00 00 000.00 00.000
P2 000,000 00.000000 000.00 000.00 00 000.00 00.00
O 00,000 00.000000 000.00 000.00 000.00 0.000
P 00,000 00.000000
P 0,000 00.000000
P 00,000 00.000000
O 15,637 $0.592239
O 74,300 $0.592239
To view MaaT Pharma’s complete cap table history, request access »

MaaT Pharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of microbiome restoration biotherapeutics designed to improve the survival outcome of blood cancer. The compan
Drug Discovery
Lyon, France
34 As of 2020
000.00
00.00 0000-00-00
00000000000 000.00

00000 00

olor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore mag
0000 000000000
Waltham, MA
00 As of 0000
000.00
00.00 0000-00-00
00000000000 000.00

00000 00

t dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut al
0000000000000
Cambridge, MA
000 As of 0000
00000
00000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

MaaT Pharma Competitors (18)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Axial Therapeutics Venture Capital-Backed Waltham, MA 00 000.00 00000000000 000.00
00000 000000000000 Formerly VC-backed Cambridge, MA 000 00000 00000000 00000
00000000 Venture Capital-Backed Cambridge, MA 000.00 0000000000 0 000.00
00000 (0000 000000 Venture Capital-Backed Somerville, MA 000 00000 00000000000 00000
000000 000000 Venture Capital-Backed Brisbane, CA 00 000.00 00000000000 000.00
You’re viewing 5 of 18 competitors. Get the full list »

MaaT Pharma Executive Team (11)

Name Title Board Seat Contact Info
Herve Affagard Co-Founder, Chief Executive Officer & Board Member
Siân Crouzet Chief Operating Officer
Savita Bernal Chief Business Officer
Mohamad Mohty MD Co-Founder & Medical Haematology-Oncology Advisor
Joel Dore Ph.D Co-Founder & Scientific Advisor
You’re viewing 5 of 11 executive team members. Get the full list »

MaaT Pharma Board Members (10)

Name Representing Role Since
Claude Bertrand MaaT Pharma Board Member 000 0000
Herve Affagard MaaT Pharma Co-Founder, Chief Executive Officer & Board Member 000 0000
Isabelle de Cremoux Seventure Partners Board Member 000 0000
Jean-Marie Lefevre MaaT Pharma Chairman of the Board 000 0000
Julien Samson Self Board Member 000 0000
You’re viewing 5 of 10 board members. Get the full list »

MaaT Pharma Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

MaaT Pharma Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Bpifrance Sovereign Wealth Fund Minority 000 0000 000000 0
Celeste Management (Switzerland) Family Office Minority 000 0000 000000 0
Skyviews Life Science Corporation Minority 000 0000 000000 0
SymBiosis Corporation Minority 000 0000 000000 0
BigBooster Accelerator/Incubator Minority 000 0000 000000 0
You’re viewing 5 of 9 investors. Get the full list »